Inventory / revenue moved 2275 bp lower
Inventory / revenue changed -2275 basis points from the comparable as-filed period.
122.13%→99.38%2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →TRN financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Revenue increased 17.8%
Revenue changed +17.8% from the comparable as-filed period.
$454.1M→$535.1M2 prior comparisons
Capital expenditure increased 87.6%
Capital expenditure changed +87.6% from the comparable as-filed period.
$8.9M→$16.7M2 prior comparisons
Shares outstanding decreased 2.5%
Shares outstanding changed -2.5% from the comparable as-filed period. The change ranks at the 75th percentile of 8 prior comparable changes.
80,180,523→78,186,0828 prior comparisons
Capex / revenue moved 116 bp higher
Capex / revenue changed +116 basis points from the comparable as-filed period.
1.96%→3.12%2 prior comparisons
Operating cash-flow margin moved 266 bp higher
Operating cash-flow margin changed +266 basis points from the comparable as-filed period.
9.73%→12.39%2 prior comparisons
Selling, general & administrative increased 21.9%
Selling, general & administrative changed +21.9% from the comparable as-filed period.
$45.2M→$55.1M2 prior comparisons
SBC / revenue moved 12 bp lower
SBC / revenue changed -12 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
1.30%→1.18%2 prior comparisons
Free-cash-flow margin moved 150 bp higher
Free-cash-flow margin changed +150 basis points from the comparable as-filed period.
7.77%→9.27%2 prior comparisons
Inventory decreased 4.1%
Inventory changed -4.1% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$554.6M→$531.8M4 prior comparisons
Stock-based compensation increased 6.8%
Stock-based compensation changed +6.8% from the comparable as-filed period.
$5.9M→$6.3M2 prior comparisons
Capital expenditure increased 34.5%
Capital expenditure changed +34.5% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$8.7M→$11.7M3 prior comparisons
Operating cash flow increased 11.9%
Operating cash flow changed +11.9% from the comparable as-filed period.
$61.6M→$68.9M3 prior comparisons
Inventory increased 16.1%
Inventory changed +16.1% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$459.7M→$533.6M4 prior comparisons
Revenue decreased 4.2%
Revenue changed -4.2% from the comparable as-filed period.
$506.2M→$485.1M2 prior comparisons
Free-cash-flow proxy increased 8.1%
Free-cash-flow proxy changed +8.1% from the comparable as-filed period.
$52.9M→$57.2M3 prior comparisons
Capex / revenue moved 69 bp higher
Capex / revenue changed +69 basis points from the comparable as-filed period.
1.72%→2.41%2 prior comparisons
Operating cash-flow margin moved 203 bp higher
Operating cash-flow margin changed +203 basis points from the comparable as-filed period.
12.17%→14.20%2 prior comparisons
Shares outstanding decreased 1.4%
Shares outstanding changed -1.4% from the comparable as-filed period. The change ranks at the 38th percentile of 8 prior comparable changes.
80,837,359→79,669,4868 prior comparisons
Cash & equivalents increased 5.4%
Cash & equivalents changed +5.4% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$147.7M→$155.7M4 prior comparisons
SBC / revenue moved 7 bp higher
SBC / revenue changed +7 basis points from the comparable as-filed period.
1.07%→1.13%2 prior comparisons
Free-cash-flow margin moved 134 bp higher
Free-cash-flow margin changed +134 basis points from the comparable as-filed period.
10.45%→11.79%2 prior comparisons
Cost of revenue increased 0.6%
Cost of revenue changed +0.6% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$372.8M→$375.2M2 prior comparisons
Selling, general & administrative increased 3.4%
Selling, general & administrative changed +3.4% from the comparable as-filed period.
$49.4M→$51.1M2 prior comparisons
Stock-based compensation increased 1.9%
Stock-based compensation changed +1.9% from the comparable as-filed period.
$5.4M→$5.5M2 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.